pulmonary drugs
Recently Published Documents


TOTAL DOCUMENTS

8
(FIVE YEARS 2)

H-INDEX

4
(FIVE YEARS 1)

2021 ◽  
pp. 136749352110139
Author(s):  
Guy Van Schandevyl ◽  
Georges Casimir ◽  
Laurence Hanssens

Adherence to chronic pulmonary drugs in cystic fibrosis (CF) is suboptimal. We studied the feasibility and effectiveness of a multistep medication adherence–enhancing simulation intervention for pediatric CF, which was embedded in motivational interviewing and education. Product simulation experiments were performed by the children themselves, and they addressed adherence to mucolytics/hydrators and antibiotics. Dornase alfa–treated patients aged 7–13 years were included. We invited each patient and their parents to attend an interview. PowerPoint slides were presented and discussed. The final slide invited the patient to perform the simulation experiments, and, in so doing, they experienced what happens when they either do or do not take their medication. An educational film was applied as a summary tool. A patient-centered empathic counseling style was used. Two months later, the child and their parents each completed a different anonymous questionnaire. Overall, 21 patients were included. Parents rated the means of communication and improvement in their child’s motivation as very satisfactory. Children highly appreciated the experiments they performed. They often answered two questions on dornase alfa correctly and associated knowledge with adherence. Our results suggest that experiential simulation-based learning is extremely appropriate, and that this multistep intervention is feasible and effective in pediatric CF.


2020 ◽  
Vol 2 (10) ◽  
pp. 1707-1708 ◽  
Author(s):  
Zainab Gandhi ◽  
Zeeshan Mansuri ◽  
Snehal Bansod

2018 ◽  
Vol 9 (1) ◽  
pp. 47-70 ◽  
Author(s):  
Gabriela Daisy Hadiwinoto ◽  
Philip Chi Lip Kwok ◽  
Richard Lakerveld
Keyword(s):  

ChemInform ◽  
2014 ◽  
Vol 45 (17) ◽  
pp. no-no
Author(s):  
Caina Xu ◽  
Huayu Tian ◽  
Xuesi Chen

TECHNOLOGY ◽  
2014 ◽  
Vol 02 (01) ◽  
pp. 75-81 ◽  
Author(s):  
C.S. Tsai ◽  
R.W. Mao ◽  
S.K. Lin ◽  
Y. Zhu ◽  
S.C. Tsai

We report here the technology and the underlying science of a new device for inhalation (pulmonary) drug delivery which is capable of fulfilling needs unmet by current commercial devices. The core of the new device is a centimeter-size clog-free silicon-based ultrasonic nozzle with multiple Fourier horns in resonance at megahertz (MHz) frequency. The dramatic resonance effect among the multiple horns and high growth rate of the MHz Faraday waves excited on a medicinal liquid layer together facilitate ejection of monodisperse droplets of desirable size range (2–5 μm) at low electrical drive power (<1.0 W). The small nozzle requiring low drive power has enabled realization of a pocket-size (8.6 × 5.6 × 1.5 cm3) ultrasonic nebulizer. A variety of common pulmonary drugs have been nebulized using the pocket-size unit with desirable aerosol sizes and output rate. These results clearly provide proof-of-principle for the new device and confirm its potential for commercialization.


2014 ◽  
Vol 32 (1) ◽  
pp. 13-21 ◽  
Author(s):  
Caina Xu ◽  
Huayu Tian ◽  
Xuesi Chen

Author(s):  
Aubrey A. Larsen ◽  
Kendrick W. Dungan
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document